China’s FDA Verifies Data from 55 Clinical Trials in First Wave of International Audits

Drug Industry Daily
As part of its clinical trial data auditing initiative, the Chinese Food and Drug Administration verified data from an initial set of 55 clinical trials, focusing mainly on large, international drugmakers.

To View This Article:


Subscribe To Drug Industry Daily